Amgen, Inc.
Complete recall history across all FDA and CPSC categories — 7 total recalls
Amgen, Inc. appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.
Drug Recalls (7)
FDA drug safety enforcement actions by Amgen, Inc.
| Date | Product | Reason | Class |
|---|---|---|---|
| Feb 27, 2025 | Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL si... | Stability data does not support expiry: the products have the potential to be... | Class II |
| Feb 27, 2025 | Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx ... | Stability data does not support expiry: the products have the potential to be... | Class II |
| May 2, 2022 | MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution,... | Defective container: loose crimp defect, potential loss of container integrity. | Class II |
| Sep 13, 2017 | Procrit (epoetin alfa), 10,000 units/mL, packaged in a) box of 6 single use 1... | Presence of particulate matter: glass flakes identified as lamellae observed ... | Class II |
| Aug 4, 2017 | Procrit Epoetin Alfa 40,000 units/mL single use vial For Intravenouse or Subc... | Presence of particulate matter: Visible glass flakes identified as lamellae i... | Class II |
| Dec 15, 2016 | AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused p... | Lack of Assurance of Sterility: Potential cracks in glass vials | Class II |
| Sep 17, 2013 | Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syring... | Presence of Particulate Matter: Visible cellulose fibers were observed in a s... | Class II |
Frequently Asked Questions
A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.
Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.
The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.
Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.
Explore More Recalls
Search recalls by category, state, reason, or firm across all our databases.